Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_assertion description "[Some studies have confirmed that Ethyl pyruvate (EP), a potent inhibitor of HMGB1, exerts the therapeutic effects on metastatic live tumor from gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_assertion evidence source_evidence_literature NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_assertion SIO_000772 23298486 NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_assertion wasDerivedFrom befree-2016 NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_assertion wasGeneratedBy ECO_0000203 NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.
- befree-2016 importedOn "2016-02-19" NP1041663.RAQGNC0mklY3v8J99y-LI_migEV-caW8EL3DWl7bh6Qqc130_provenance.